Select a community
ALS including PLS and PMA
Find out more about the PatientsLikeMe
ALS Community
Home > Community Treatment Reports > Omeprazole Treatment Report
What is Omeprazole?

Omeprazole decreases the amount of acid produced in the stomach. It is used to treat duodenal and gastric ulcer disease, gastroesophageal reflux disease (GERD) and Zollinger-Ellison syndrome, a hypersecretory condition. OTC preparations are used for frequent, uncomplicated heartburn.

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
0 0%
Mild
1 17%
None
5 83%

Most commonly reported side effects

digestive disturbances such as loud burping
1 17%
  • Mild
  • Moderate
  • Severe

Dosages

  20mg as needed daily 1 mg daily 10 mg daily 20 mg 20 mg daily 20 mL daily 30 mg daily 40 mg daily 80 mg daily
  2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 4 Number of Patients: 4 1 Number of Patients: 1 35 Number of Patients: 35 1 Number of Patients: 1 1 Number of Patients: 1 13 Number of Patients: 13 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Omeprazole (multiple reasons could be selected)
Reason # Patients Percentage of patients
Other
5 63% Other: 63%
Course of treatment ended
4 50% Course of treatment ended: 50%
Did not seem to work
1 13% Did not seem to work: 13%

See all 8 patients who’ve stopped taking Omeprazole

Currently Taking Omeprazole

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
1
0
1
7
5
18

Stopped Taking Omeprazole

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
2
1
2
1
1
1

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
6 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
6 100%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
1 17%
< $25
2 33%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 21, 2009.